Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picksnews2024-11-28T02:32:29+00:00November 28th, 2024|The New York Times|
Obesity Drugs Would Be Covered by Medicare and Medicaid Under Biden Proposalnews2024-11-26T21:15:23+00:00November 26th, 2024|The New York Times|
Can RFK Jr. Limit Ozempic Access as HHS Chief? Here’s What to Knownews2024-11-22T21:06:45+00:00November 22nd, 2024|The New York Times|
Biden Officials Stave Off Sticker Shock on Medicare Drug Premiumsnews2024-09-27T20:00:11+00:00September 27th, 2024|The New York Times|
U.S. Makes Initial Offers in Medicare Drug Price Negotiationsnews2024-02-01T18:36:19+00:00February 1st, 2024|The New York Times|
Medicare Open Enrollment Is Starting. Here’s How to Navigate the Ad Blitz.news2023-10-14T09:01:47+00:00October 14th, 2023|The New York Times|
Biden Administration Unveils First Drugs for Medicare Price Negotiationsnews2023-08-29T22:50:39+00:00August 29th, 2023|The New York Times|
New RSV Vaccines Aren’t Covered by Some Health Insurance Plansnews2023-08-25T19:55:21+00:00August 25th, 2023|The New York Times|
Drugmakers Throw ‘Kitchen Sink’ to Halt Medicare Price Negotiationsnews2023-07-23T07:00:18+00:00July 23rd, 2023|The New York Times|
FDA Makes Alzheimer’s Drug Leqembi Widely Accessiblenews2023-07-06T21:26:16+00:00July 6th, 2023|The New York Times|